Technical Analysis for DRUG - Bright Minds Biosciences Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Inside Day | Range Contraction | -2.54% | |
Gapped Up | Strength | -2.54% | |
Oversold Stochastic | Weakness | -2.54% | |
Stochastic Reached Oversold | Weakness | 0.88% | |
Oversold Stochastic | Weakness | 0.88% | |
20 DMA Resistance | Bearish | 0.88% | |
Outside Day | Range Expansion | 0.88% | |
Gapped Up | Strength | 0.88% | |
Fell Below 20 DMA | Bearish | -6.50% | |
Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -6.50% |
Alert | Time |
---|---|
Gap Down Partially Closed | about 1 hour ago |
Gapped Down (Partial) | about 1 hour ago |
Down 3% | about 1 hour ago |
Down 2 % | about 1 hour ago |
Down 1% | about 1 hour ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 08/28/2023
Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. The company was incorporated in 2019 and is headquartered in Vancouver, Canada.
Sector: Healthcare
Industry: Biotechnology
Keywords: Drugs Pain Organic Compounds Chemical Compounds Epilepsy Antidepressants Neurotransmitters Treatment Of Epilepsy
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Drugs Pain Organic Compounds Chemical Compounds Epilepsy Antidepressants Neurotransmitters Treatment Of Epilepsy
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 6.44 |
52 Week Low | 1.09 |
Average Volume | 22,883 |
200-Day Moving Average | 1.90 |
50-Day Moving Average | 1.52 |
20-Day Moving Average | 1.23 |
10-Day Moving Average | 1.21 |
Average True Range | 0.12 |
RSI (14) | 40.83 |
ADX | 22.74 |
+DI | 11.08 |
-DI | 19.60 |
Chandelier Exit (Long, 3 ATRs) | 1.09 |
Chandelier Exit (Short, 3 ATRs) | 1.45 |
Upper Bollinger Bands | 1.37 |
Lower Bollinger Band | 1.09 |
Percent B (%b) | 0.32 |
BandWidth | 22.41 |
MACD Line | -0.08 |
MACD Signal Line | -0.09 |
MACD Histogram | 0.0099 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.31 | ||||
Resistance 3 (R3) | 1.31 | 1.26 | 1.29 | ||
Resistance 2 (R2) | 1.26 | 1.23 | 1.26 | 1.28 | |
Resistance 1 (R1) | 1.22 | 1.20 | 1.19 | 1.22 | 1.28 |
Pivot Point | 1.17 | 1.17 | 1.16 | 1.17 | 1.17 |
Support 1 (S1) | 1.13 | 1.14 | 1.11 | 1.14 | 1.08 |
Support 2 (S2) | 1.08 | 1.11 | 1.08 | 1.08 | |
Support 3 (S3) | 1.04 | 1.08 | 1.07 | ||
Support 4 (S4) | 1.05 |